Back to Search Start Over

Structure-Activity Relationship of Truncated 4'-Selenonucleosides: A 3 Adenosine Receptor Activity and Binding Selectivity.

Authors :
Kim M
Choi H
Nayak A
Tripathi SK
Aswar VR
Gaikwad VB
Jacobson KA
Jeong LS
Source :
ACS medicinal chemistry letters [ACS Med Chem Lett] 2024 Aug 22; Vol. 15 (9), pp. 1620-1626. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
Publication Year :
2024

Abstract

This study explored the impact of structural modifications on truncated 4'-selenonucleosides as ligands for the A <subscript>3</subscript> adenosine receptor (AR). We synthesized and evaluated a series of these compounds for their binding affinities, functional activities, and structural interactions by using computational modeling. The SAR study revealed that all compounds exhibited selective and notable hA <subscript>3</subscript> AR binding, among which 6l ( K <subscript>i</subscript> = 5.2 nM) and 6m ( K <subscript>i</subscript> = 5.7 nM) were found as the best binding compounds. The representative N <superscript>6</superscript> -cyclopropyl compound 6m was found to be a partial agonist, contrasting with the antagonist profiles of truncated 4'-oxo and 4'-thionucleosides. Computational docking highlighted 6m 's unique interaction with Thr94 at the A <subscript>3</subscript> AR binding site. This research not only advances our understanding of A <subscript>3</subscript> AR ligand interactions but also highlights the potential of truncated 4'-selenonucleosides as effective A <subscript>3</subscript> AR modulators.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2024 American Chemical Society.)

Details

Language :
English
ISSN :
1948-5875
Volume :
15
Issue :
9
Database :
MEDLINE
Journal :
ACS medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
39420956
Full Text :
https://doi.org/10.1021/acsmedchemlett.4c00344